PDCD1 and Carcinoma, Lewis Lung: Anti-PD-1 mAb combined with apigenin could effectively enhance the cytotoxic effect of CD8+ T cells with an increased level of TNF-α, IFN-γ, and granzyme B in the Lewis lung carcinoma model that did not respond to treatment with anti-PD-1 mAb alone [87].